aldosterone has been researched along with Brain Vascular Disorders in 31 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Allisartan isoproxil (ALL) is a new angiotensin II receptor blocker and a new antihypertensive drug discovered and developed in China." | 5.62 | Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage. ( Cheng, MH; Fu, FH; Ling, QS; Liu, AJ; Liu, JG; Miao, CY; Tian, JS; Zhang, SL, 2021) |
| " We measured the urinary excretion of 19-noraldosterone in the spontaneously hypertensive rat (SHR) and stroke-prone SHR (SHRSP) during the development of hypertension and compared these measurements with Wistar-Kyoto (WKY) rats." | 3.69 | Urinary excretion of 19-noraldosterone in the spontaneously hypertensive rat and stroke-prone spontaneously hypertensive rat. ( Hurukawa, K; Inaba, S; Ito, Y; Miyamori, I; Takeda, R; Takeda, Y; Yoneda, T, 1995) |
| "Elevations in plasma aldosterone enhance stroke development within captopril-treated SHRSP through mechanisms that do not involve stimulation of mineralocorticoid receptors or the enhancement of hypertension." | 3.69 | The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats. ( MacLeod, AB; Smeda, JS; Vasdev, S, 1997) |
| "Aldosterone is a mineralocorticoid hormone that participates in the regulation of electrolyte balance, blood pressure, and tissue remodeling." | 2.61 | Endothelial Dysfunction in Primary Aldosteronism. ( Chen, ZW; Chou, CH; Hung, CS; Liao, CW; Lin, YH; Pan, CT; Tsai, CH; Wu, VC, 2019) |
| "Moreover, primary aldosteronism patients are exposed to an increased risk of cardio and cerebrovascular events and metabolic comorbidities compared with patients affected by essential hypertension." | 2.58 | Primary aldosteronism in the primary care setting. ( Buffolo, F; Monticone, S; Mulatero, P; Tetti, M, 2018) |
| "Aldosterone has also been demonstrated to be a major factor in target organ damage independent of its effects on blood pressure." | 2.44 | Aldosterone as an independent factor in cerebrovascular damage. ( Bertello, C; Caserta, M; Giraudo, G; Morello, F; Mulatero, P; Schiavone, D; Veglio, F; Verhovez, A, 2008) |
| "Allisartan isoproxil (ALL) is a new angiotensin II receptor blocker and a new antihypertensive drug discovered and developed in China." | 1.62 | Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage. ( Cheng, MH; Fu, FH; Ling, QS; Liu, AJ; Liu, JG; Miao, CY; Tian, JS; Zhang, SL, 2021) |
| "Mean aldosterone levels were highest in the TT group and lowest in CC group (p = 0." | 1.48 | Modulation of aldosterone levels by aldosterone synthase promoter polymorphism and association with eGFR decline in patients with chronic kidney disease. ( Gu, Y; Hao, C; Lai, L; Qian, J; Shi, H; Yan, M; Zhong, J, 2018) |
| "Both fibrinogen and PAI-1 were independent predictors of the presence of organ damage and their inclusion in a multivariate model eliminated PRA and aldosterone as independent predictors." | 1.35 | Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage. ( Casanova-Borca, A; Catena, C; Chiuch, A; Colussi, G; Di Fabio, A; Nadalini, E; Novello, M; Sechi, LA; Uzzau, A, 2008) |
| "Special treatment for hyponatremia was not given in 30 of the 58 cases (control group)." | 1.28 | [Mechanism and therapy of hyponatremia with central origin]. ( Morinaga, K; Ohkawara, S; Tabuse, H, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (38.71) | 18.7374 |
| 1990's | 10 (32.26) | 18.2507 |
| 2000's | 3 (9.68) | 29.6817 |
| 2010's | 5 (16.13) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZW | 1 |
| Tsai, CH | 1 |
| Pan, CT | 1 |
| Chou, CH | 1 |
| Liao, CW | 1 |
| Hung, CS | 1 |
| Wu, VC | 1 |
| Lin, YH | 1 |
| Ling, QS | 1 |
| Zhang, SL | 1 |
| Tian, JS | 1 |
| Cheng, MH | 1 |
| Liu, AJ | 1 |
| Fu, FH | 1 |
| Liu, JG | 1 |
| Miao, CY | 1 |
| Buffolo, F | 1 |
| Monticone, S | 1 |
| Tetti, M | 1 |
| Mulatero, P | 2 |
| Qian, J | 1 |
| Zhong, J | 1 |
| Yan, M | 1 |
| Shi, H | 1 |
| Hao, C | 1 |
| Gu, Y | 1 |
| Lai, L | 1 |
| Lu, ZH | 1 |
| Zhu, XX | 1 |
| Tang, ZQ | 1 |
| Yang, GQ | 1 |
| Du, J | 1 |
| Wang, XL | 1 |
| Yang, JZ | 1 |
| Gu, WJ | 1 |
| Guo, QH | 1 |
| Jin, N | 1 |
| Yang, LJ | 1 |
| Ba, JM | 1 |
| Dou, JT | 1 |
| Mu, YM | 1 |
| Dézsi, CA | 1 |
| Sechi, LA | 1 |
| Novello, M | 1 |
| Colussi, G | 1 |
| Di Fabio, A | 1 |
| Chiuch, A | 1 |
| Nadalini, E | 1 |
| Casanova-Borca, A | 1 |
| Uzzau, A | 1 |
| Catena, C | 1 |
| Caserta, M | 1 |
| Bertello, C | 1 |
| Schiavone, D | 1 |
| Verhovez, A | 1 |
| Giraudo, G | 1 |
| Morello, F | 1 |
| Veglio, F | 1 |
| Skvortsova, VI | 1 |
| Platonova, IA | 1 |
| Tvorogova, TV | 1 |
| Volkovenko, OV | 1 |
| Demidova, LI | 1 |
| Ostrovtsev, IV | 1 |
| Unger, T | 1 |
| Yukimura, T | 1 |
| Marin-Grez, M | 1 |
| Lang, RE | 1 |
| Rascher, W | 1 |
| Ganten, D | 2 |
| Stasiński, T | 1 |
| Lehmann, Z | 1 |
| Kostka-Wach, M | 1 |
| Biryńczyk, J | 1 |
| Warenik-Szymankiewicz, A | 1 |
| Laragh, JH | 2 |
| Volpe, M | 3 |
| Rubattu, S | 2 |
| Enea, I | 1 |
| Russo, R | 1 |
| Lembo, G | 3 |
| Mirante, A | 1 |
| Condorelli, G | 2 |
| Trimarco, B | 2 |
| Graf, C | 1 |
| Maser-Gluth, C | 1 |
| de Muinck Keizer, W | 1 |
| Rettig, R | 1 |
| Takeda, Y | 1 |
| Miyamori, I | 1 |
| Yoneda, T | 1 |
| Hurukawa, K | 1 |
| Inaba, S | 1 |
| Ito, Y | 1 |
| Takeda, R | 1 |
| MacLeod, AB | 1 |
| Vasdev, S | 1 |
| Smeda, JS | 1 |
| Stasch, JP | 1 |
| Knorr, A | 1 |
| Hirth-Dietrich, C | 1 |
| Krämer, T | 1 |
| Hübsch, W | 1 |
| Dressel, J | 1 |
| Fey, P | 1 |
| Beuck, M | 1 |
| Sander, E | 1 |
| Frobel, K | 1 |
| Kazda, S | 1 |
| Amery, A | 1 |
| Wasir, H | 1 |
| Bulpitt, C | 1 |
| Conway, J | 1 |
| Fagard, R | 1 |
| Lijnen, P | 1 |
| Reybrouck, T | 1 |
| Zweifler, AJ | 1 |
| Esler, M | 1 |
| Omae, T | 1 |
| Perez-Stable, EC | 1 |
| Materson, BJ | 1 |
| Kim, S | 2 |
| Tokuyama, M | 1 |
| Hosoi, M | 2 |
| Yamamoto, K | 2 |
| De Luca, N | 1 |
| Lamenza, F | 1 |
| Tritto, C | 2 |
| Ricciardelli, B | 1 |
| Molaro, M | 1 |
| De Campora, P | 1 |
| Rendina, V | 1 |
| Mele, AF | 1 |
| deCampora, P | 1 |
| Condorelli, M | 1 |
| Shimamoto, K | 1 |
| Takada, T | 1 |
| Morinaga, K | 2 |
| Matsuoka, T | 1 |
| Matsumoto, Y | 1 |
| Ohmiya, N | 1 |
| Mikami, J | 1 |
| Ueda, M | 1 |
| Sato, H | 1 |
| Takahashi, Y | 1 |
| Inoue, Y | 1 |
| Takeda, S | 1 |
| Tabuse, H | 1 |
| Ohkawara, S | 1 |
| Fedirko, MI | 1 |
| Ershova, GS | 1 |
| Brunner, HR | 1 |
| Baer, L | 1 |
| Newton, MA | 1 |
| Goodwin, FT | 1 |
| Krakoff, LR | 1 |
| Bard, RH | 1 |
| Bühler, FR | 1 |
| Wood, JE | 1 |
| Kloppenborg, PW | 1 |
| Drayer, JI | 1 |
| Van Haelst, AJ | 1 |
| Benraad, HB | 1 |
| Van't Laar, A | 1 |
| Smals, AG | 1 |
| Benraad, TJ | 1 |
8 reviews available for aldosterone and Brain Vascular Disorders
| Article | Year |
|---|---|
Endothelial Dysfunction in Primary Aldosteronism.
Topics: Aldosterone; Cardiovascular Diseases; Cerebrovascular Disorders; Disease Progression; Humans; Hypera | 2019 |
Primary aldosteronism in the primary care setting.
Topics: Adrenalectomy; Aldosterone; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Huma | 2018 |
The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressu | 2016 |
Aldosterone as an independent factor in cerebrovascular damage.
Topics: Aldosterone; Animals; Blood Pressure; Cerebrovascular Disorders; Disease Models, Animal; Humans; Hyp | 2008 |
[Effect of oral contraceptives on the circulatory system].
Topics: Aldosterone; Angiotensin II; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Ora | 1980 |
Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke).
Topics: Aldosterone; Animals; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Electrolyt | 1995 |
Aging and the cardiovascular system.
Topics: Aged; Aging; Aldosterone; Angiotensin II; Antihypertensive Agents; Blood Pressure; Cardiac Output; C | 1978 |
The cardiovascular effects of oral contraceptives.
Topics: Aldosterone; Angiotensin II; Blood Coagulation; Blood Flow Velocity; Blood Vessels; Cardiovascular S | 1972 |
23 other studies available for aldosterone and Brain Vascular Disorders
| Article | Year |
|---|---|
Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Aorti | 2021 |
Modulation of aldosterone levels by aldosterone synthase promoter polymorphism and association with eGFR decline in patients with chronic kidney disease.
Topics: Adult; Aged; Aldosterone; Cardiovascular Diseases; Cerebrovascular Disorders; Cytochrome P-450 CYP11 | 2018 |
Female sex hormones are associated with the reduction of serum sodium and hypertension complications in patients with aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Biomarkers; Cerebrovascular Disorders; | 2013 |
Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage.
Topics: Adult; Aldosterone; Algorithms; Analysis of Variance; Biomarkers; Cerebrovascular Disorders; Cross-S | 2008 |
[The influence of the hormones of hypothalamo-pituitary-adrenal, renin-angiotensin, and thyroid hormonal systems on formation of vascular encephalopathy].
Topics: Adrenocorticotropic Hormone; Aged; Aldosterone; Analysis of Variance; Cerebrovascular Circulation; C | 2003 |
SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
Topics: 3-Mercaptopropionic Acid; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypert | 1982 |
Dietary salt excess unmasks blunted aldosterone suppression and sodium retention in the stroke-prone phenotype of the spontaneously hypertensive rat.
Topics: Administration, Oral; Aldosterone; Animals; Blood Pressure; Body Weight; Cerebrovascular Disorders; | 1993 |
Sodium retention and hypertension after kidney transplantation in rats.
Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Cerebrovascular Disorders; Diet; Hypertension; Ki | 1993 |
Urinary excretion of 19-noraldosterone in the spontaneously hypertensive rat and stroke-prone spontaneously hypertensive rat.
Topics: Aldosterone; Animals; Cerebrovascular Disorders; Chromatography, High Pressure Liquid; Hypertension; | 1995 |
The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cerebral | 1997 |
Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modifie | 1997 |
Factors influencing the choice of antihypertensive agents.
Topics: Age Factors; Aldosterone; Cerebrovascular Disorders; Clonidine; Depression; Diabetes Complications; | 1976 |
[Disturbances of autoregulation in stroke. (2) The Renin-angiotensin-aldosterone system].
Topics: Adult; Aged; Aldosterone; Angiotensin II; Animals; Cerebrovascular Disorders; Humans; Male; Middle A | 1976 |
Workup of the newly discovered hypertensive patient.
Topics: Adult; Aldosterone; Angiotensin II; Cardiac Output; Cerebrovascular Disorders; Contraceptives, Oral; | 1975 |
Adrenal and circulating renin-angiotensin system in stroke-prone hypertensive rats.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Cerebrovascular Disorders; Concanavalin A; Enz | 1992 |
Abnormal hormonal and renal responses to saline load in hypertensive patients with parental history of cardiovascular accidents.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Cerebrovascular Disorders; Family Hea | 1991 |
Impairment of atrial natriuretic factor response to acute saline load in hypertensives with family history of cardiovascular accidents.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Cerebrovascular Disorders; Female; Humans; Hypertensi | 1991 |
Increased production of angiotensin II in the adrenal gland of stroke-prone spontaneously hypertensive rats with malignant hypertension.
Topics: Adrenal Glands; Aging; Aldosterone; Angiotensin I; Angiotensin II; Animals; Cerebrovascular Disorder | 1991 |
[Mechanism of hyponatremia in the acute phase of cerebrovascular diseases].
Topics: Adult; Aged; Aldosterone; Blood Urea Nitrogen; Cerebrovascular Disorders; Humans; Hyponatremia; Midd | 1987 |
[Mechanism and therapy of hyponatremia with central origin].
Topics: Aldosterone; Cerebrovascular Disorders; Craniocerebral Trauma; Glucose; Humans; Hydrocortisone; Hypo | 1989 |
[Renin-angiotensin-aldosterone system in hypertension patients who have had a cerebral stroke].
Topics: Aged; Aldosterone; Cerebrovascular Disorders; Chronic Disease; Humans; Hypertension; Middle Aged; Re | 1987 |
Essential hypertension: renin and aldosterone, heart attack and stroke.
Topics: Adult; Aldosterone; Cardiomegaly; Cerebrovascular Disorders; Female; Humans; Hypertension; Male; Mid | 1972 |
Primary aldosteronism, idiopathic aldosteronism and "low-renin" benign essential hypertension. A retrospective study.
Topics: Adult; Age Factors; Aged; Aldosterone; Blood Pressure; Cerebrovascular Disorders; Female; Humans; Hy | 1974 |